Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: The missing piece in the puzzle of their increased cardiovascular risk?-Reference-Cited by-同舟云学术

Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: The missing piece in the puzzle of their increased cardiovascular risk?

Published:2014-11-19 Issue:2 Volume:90 Page:109-113
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Vianello Fabrizio¹,Cella Giuseppe²,Osto Elena³,Ballin Andrea²,Famoso Giulia²,Tellatin Sara²,Iliceto Sabino²,Cucchini Umberto²,Saggiorato Graziella²,Omenetto Elisabetta²,Tona Francesco²

Affiliation:

1. Department of Medicine DIMED; University Hospital; Padua Italy

2. Department of Cardiac; Thoracic and Vascular Sciences; University Hospital; Padua Italy

3. Cardiovascular Center; University Hospital and Cardiovascular Research; Institute of Physiology; Zurich Switzerland

Funder

University of Padova Funds for Institutional Research

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23881/fullpdf

Reference33 articles.

1. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients;Carobbio;Blood,2011

2. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status;Arellano-Rodrigo;Haematologica,2006

3. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera;Falanga;Exp Hematol,2005

4. Thrombosis in myeloproliferative disorders: Pathogenetic facts and speculation;Landolfi;Leukemia,2008

5. Bleeding and thrombosis in myeloproliferative disorders: Mechanisms and treatment;Landolfi;Crit Rev Oncol Hematol,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risikofaktoren und Prävention im Licht der Atherosklerose als Mikrozirkulationskrankheit;Atherosklerose-Pathogenese und mikrovaskuläre Dysfunktion;2023

2. Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis;Medicina Clínica (English Edition);2022-06

3. Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm;The Korean Journal of Internal Medicine;2021-09-01

4. The Assessment of the Platelet Function During the Acute Phase of ST-segment Elevation Myocardial Infarction in Essential Thrombocythemia;Internal Medicine;2021-08-15

5. The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms;European Heart Journal;2021-08-03